CardiaCare

CardiaCare is a pioneering medical equipment manufacturing company dedicated to transforming the treatment of Atrial Fibrillation (AFib). CardiaCare has developed the world's first wearable therapy designed to reduce the burden of this widespread arrhythmia, which affects millions globally. Utilizing non-invasive peripheral neuromodulation, CardiaCare's innovative technology mediates a cardiovascular anti-arrhythmic response through a closed-loop approach involving both monitoring and therapy.

Located at 8 Pinchas Sapir St, Ness Tsiona, Israel, CardiaCare is driven by expert leadership and supported by enthusiastic investors. The company is advancing towards its first regulatory human clinical trial, marking a significant step in making its groundbreaking therapy available to those in need. CardiaCare's commitment to innovation positions it as a key player in the evolving landscape of cardiac care.

With its unique approach and dedication to improving patient outcomes, CardiaCare continues to focus on expanding its research and development efforts. The company aims to set new standards in AFib treatment. We invite the management team at CardiaCare to enhance your company’s visibility further by creating a customized and exclusive company showcase and product listing on our platform.